Research Compares MENOPUR(R) With RFSH In GnRH Antagonist IVF Cycles

Ferring Pharmaceuticals presented an interim study analysis indicating that MENOPUR® (menotropins for injection, USP) is effective in in vitro fertilization (IVF) cycles using a gonadotropin-releasing hormone (GnRH) antagonist. The results were presented in a poster at the 65th Annual Meeting of the American Society for Reproductive Medicine (ASRM) in Atlanta, October 17-21, 2009. MENOPUR® vs.

source : www.medicalnewstoday.com

Related News:

• Subretinal Implant Restores Unprecedented Level Of Vision To Blind Patients
• Acucela And Otsuka Pharmaceutical Receive FDA Fast Track Designation For ACU-4429 In Patients With Dry AMD
• Impact Of Ethnicity On Primary Treatment Choice And Mortality In Men With Prostate Cancer: Data From CaPSURE
• Greater Infection Risk with Staples in Hip Surgery (CME/CE)
• SGO: No Lung CA Risk Seen with Estrogen (CME/CE)
• Patients With Long-Term Conditions Need Greater Support To Return To Work, England
• BrainPort Helps Blinded Soldier See With Tongue
• Insufficiency Fractures After Pelvic Radiotherapy In Patients With Prostate Cancer
• Greater Infection Risk with Staples in Hip Surgery
• SIR: ABI Flags Those Not Otherwise at Risk for CVD